Wednesday, June 15, 2016

Drug Regulator maps out new site inspection norms for safer medicines

The Central Drug Standard Control Organisation (CDSCO) is drawing up a new inspection model for pharmaceutical manufacturing sites that will help identify compliance issues and products that can be potentially harmful. The move follows concerns raised by foreign drug regulators over quality of medicines produced in India.


Post a Comment